MKK3 as oncotarget

Aging (Albany NY). 2016 Jan;8(1):1-2. doi: 10.18632/aging.100878.
No abstract available

Keywords: RNA interference; drugs dose reduction; gene targeting; mitogen-activated protein kinase; tumour therapy.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Biomarkers, Tumor / antagonists & inhibitors*
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Cell Survival / drug effects
  • Drug Resistance, Neoplasm
  • Humans
  • MAP Kinase Kinase 3 / antagonists & inhibitors*
  • MAP Kinase Kinase 3 / genetics
  • MAP Kinase Kinase 3 / metabolism
  • Molecular Targeted Therapy*
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology
  • Neoplasms / genetics
  • Neoplasms / pathology
  • Protein Kinase Inhibitors / therapeutic use*
  • Signal Transduction / drug effects

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Protein Kinase Inhibitors
  • MAP Kinase Kinase 3
  • MAP2K3 protein, human